Send me a link:

*Text messaging rates may apply.

 Dow Down 0.75% Nasdaq Down 0.57%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
49.80 Down 1.28(2.51%) 12:06PM EDT - Nasdaq Real Time Price
Prev Close:51.08
Open:50.65
Bid:49.84 x 100
Ask:49.90 x 100
1y Target Est:83.80
Beta:0.95
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:49.52 - 50.91
52wk Range:36.82 - 80.42
Volume:72,461
Avg Vol (3m):303,544
Market Cap:1.03B
P/E (ttm):85.42
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDDown 2.51%1.03B
LLYDown 0.82%68.48B
MRKDown 0.03%170.07B
RHHBYDown 0.75%251.04B

Key Statistics

Forward P/E (1 yr):20.58
P/S (ttm):19.87
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.44
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback